Pangen Biotech Inc. is based in South Korea, with the head office in Suwon. The enterprise operates in the Research and Development in Nanotechnology industry. It was established on January 29, 2010. 51 - 100 (2025) employees currently work for Pangen Biotech Inc.. The company’s latest financial report indicates a net sales revenue increase of 5.82% in Q3C2025. Its total assets grew by 29.13% over the same period. In 2025, Pangen Biotech Inc.’s net profit margin increased by 5.6%.

Headquarters
4F, 2-Dong, 306, Sinwon-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do
Suwon; Gyeonggi;

Contact Details: Purchase the Pangen Biotech Inc. report to view the information.

Website: http://www.pangen.com

Basic Information

Total Employees:

Purchase the Pangen Biotech Inc. report to view the information.

Outstanding Shares:

Purchase the Pangen Biotech Inc. report to view the information.

Registered Capital:

Purchase the Pangen Biotech Inc. report to view the information.

Financial Auditors:

Purchase the Pangen Biotech Inc. report to view the information.

Incorporation Date:

January 29, 2010

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

12.9%

Purchase this report to view the information.

9.4%

Purchase this report to view the information.

8.4%

Subsidiaries

(주)팬젠

Company Performance

Financial values in the chart are available after Pangen Biotech Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

5.82%▲

Total Operating Revenue

5.93%▲

Operating Profit

46.74%▲

EBITDA

25.48%▲

Net Profit/Loss for the Period

47.91%▲

Total Assets

29.13%▲

Total Equity

66.64%▲

Operating Profit Margin

4.92%▲

Net Profit Margin

5.6%▲

Return on Equity (ROE)

-0.91%▼

Debt / Equity

-9582%▼

Quick Ratio

4245%▲

Cash Ratio

0.7%▲

Pangen Biotech Inc. (South Korea)

Similar companies